Overview
Sigrid Therapeutics is a Swedish medtech and consumer health company pioneering non-pharmaceutical approaches to metabolic disease management. The company develops and commercializes products based on its proprietary SiPore® technology, a precisely engineered silica-based platform that operates mechanically in the gastrointestinal tract without systemic absorption. Its portfolio includes Glucose Stabiliser and Carb Fence, designed to support blood glucose regulation and weight management in individuals with prediabetes, type 2 diabetes, and obesity. The company's mission centers on translating over 15 years of materials science research into accessible, clinically validated solutions for preventing and treating lifestyle-related metabolic disorders.